OBJECTIVES: To assess the long-term safety, tolerability, and efficacy of duloxetine in
patients with fibromyalgia. METHODS: We report results from the 6-month extension phases …

Objectives Evaluate the efficacy and safety of duloxetine at doses up to 120 mg once daily in
patients with fibromyalgia. Methods This was a phase 3, 60-week study, which included an 8 …

The purpose of this report is to describe the overall safety profile of both short-and longer-
term duloxetine treatment of fibromyalgia. Data from four double-blind, randomized, placebo …

The primary objectives of this study were to assess the efficacy and safety of duloxetine for
reducing pain severity in fibromyalgia patients with or without current major depressive …

Objectives: We aimed to evaluate the long-term safety and efficacy of duloxetine 60 mg in
Japanese patients with fibromyalgia enrolled from a preceding randomized, placebo …

Objective: To investigate the efficacy of duloxetine in the treatment of pain and improvement
in functional impairment and quality of life in patients with fibromyalgia from a pooled …

Objective To assess the efficacy and safety of duloxetine, a serotonin and norepinephrine
reuptake inhibitor, in subjects with primary fibromyalgia, with or without current major …

Objectives: To evaluate the efficacy and safety of duloxetine 30 mg/d in adults with
fibromyalgia. Methods: This 12-week, randomized, double-blind, placebo-controlled study …

Objective: Assess the efficacy of duloxetine 60/120 mg (N= 162) once daily compared with
placebo (N= 168) in the treatment of patients with fibromyalgia, during six months of …

Objective. To investigate the efficacy of flexible dose duloxetine 60–120 mg/day on changes
in fibromyalgia (FM) symptoms assessed by the Patient Global Impression of Improvement …